Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.003 AUD | +20.00% |
|
0.00% | -14.29% |
05-16 | Avecho Biotechnology Doses First Patient in Phase III Anti-Insomnia Drug Trial | MT |
03-25 | Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-14.29% | 5.33M | |
+21.84% | 47.96B | |
+0.73% | 42.45B | |
+43.96% | 41.47B | |
+25.96% | 31.6B | |
+20.82% | 28.63B | |
-4.47% | 28.03B | |
+52.25% | 14.56B | |
+45.08% | 14.14B | |
+2.55% | 12.58B |
- Stock Market
- Equities
- AVE Stock
- News Avecho Biotechnology Limited
- Avecho Biotechnology Raises AU$2 Million Via Entitlement Offer; Shares Slip 20%